Home / Solutions / Translational Evidence Sprint
Proposed Engagement
A focused path from fragmented scientific evidence to a clearer development question.
When development decisions depend on complex or incomplete scientific information, a structured view of the evidence can help reveal what is established, what is uncertain, and what should be investigated next.
The Translational Evidence Sprint is a proposed focused engagement designed around a defined biological, therapeutic, or translational decision.
When to Consider
A Sprint may be relevant when:
- Evaluating an emerging target or therapeutic concept
- Reviewing preclinical-to-clinical translation questions
- Preparing for an internal portfolio decision
- Identifying missing evidence before a major milestone
- Comparing competing development hypotheses
- Exploring biomarker or mechanism-related uncertainties
Illustrative Workstreams
01 — Decision Framing
Identify the precise question, decision context, and evidence needs.
02 — Evidence Mapping
Organize relevant published findings and authorized source materials.
03 — Critical Appraisal
Examine evidence strength, limitations, biological relevance, and uncertainty.
04 — Translational Gap Assessment
Identify missing links between existing findings and the intended development application.
05 — Decision Package
Summarize findings, open questions, and recommended validation priorities.
Illustrative Deliverables
- Executive evidence summary
- Structured evidence matrix
- Translational gap map
- Assumption and risk register
- Prioritized next-step recommendations
Engagement Format
Indicative Planning Window: 4–6 weeks, subject to scope and feasibility confirmation.
This duration is a proposed service design, not a guaranteed turnaround for all projects.
Bring Us Your Translational Question.
Start with the decision you need to make — we will help structure the evidence around it.